Pfizer FY05 net rises 50 per cent despite weak Q4

Our Corporate Bureau
27 February 2006

For the full year ended 30 November 2005, Pfizer has reported a net profit of Rs68.12 crore, or Rs22.83 per share, as compared to Rs45.52 crore, or Rs15.25 per share, for the previous year - a growth of 49.65 per cent. Total revenues for the year were higher by 7.12 per cent at Rs639.55 crore as compared to Rs597.02 crore for the previous year.

Operating margins for the latest reporting year improved to 24.5 per cent as compared to 18.85 per cent for the previous year. Operating profits increased to Rs146.61 crore as against Rs105.13 crore, a growth of 39.46 per cent.

Consolidated net profit for the full year increased to Rs70.73 crore as compared to Rs44.59 crore for the previous year. Consolidated revenues have increased to Rs644.09 crore for the year ended 30 November 2005 from Rs607.16 crore for the previous year.

For the fourth quarter ended 30 November 2005, Pfizer India has reported a net profit of Rs17.37 crore, or Rs5.82 per share, as compared to Rs13.71 crore, or Rs4.76 per share, for the previous year quarter - a growth of 26.7 per cent. Total revenues for the quarter were higher by 20.4 per cent at Rs179.82 crore as compared to Rs149.32 crore for the previous year quarter.

Q4 profits are lower by 20.4 per cent as compared to Rs21.82 crore reported for the third quarter ended 31 August 2005. As compared to Q3, revenues increased by a meager 4 per cent.

Pfizer also saw significant erosion in operating margins, which declined from 28.4 per cent in Q3 to 20 per cent during Q4. Operating profits for the fourth quarter were at Rs33.58 crore as compared to Rs.46.24 crore for the third quarter, a decline of 27.4 per cent.